In summary, during lymphocyte differentiation, SMARCA4 and SMARCA2 affect lymphocytic function and the development of related diseases, especially leukemia and lymphoma, by enhancing chromatin accessibility and interacting with various TFs. Here, SMARCA2 is linked to leukemia.